Addiction News and Research

RSS

UTMB awarded $6.6 million grant to establish Translational Addiction Sciences Center

The National Institute on Drug Abuse has awarded a five-year, $6.6 million grant to the University of Texas Medical Branch at Galveston to establish the Translational Addiction Sciences Center. The center will investigate the mechanisms underlying addiction with the goal of discovering and validating novel treatment options.

26 Apr 2014

Methadone safety: New clinical practice guideline from American Pain Society

Improved physician education and patient counseling about methadone safety and ECG monitoring to identify patients at high risk for cardiac problems will lead to safer use of the medication, according to the American Pain Society's Clinical Practice Guideline on Methadone Safety, published this week in The Journal of Pain.

26 Apr 2014

UB research finds novel compound for treating cocaine addiction

A novel compound that targets an important brain receptor has a dramatic effect against a host of cocaine addiction behaviors, including relapse behavior, a University at Buffalo animal study has found.

25 Apr 2014

TSRI scientists identify protein complex that plays critical role in learning and memory formation

Scientists from the Florida campus of The Scripps Research Institute have identified a protein complex that plays a critical but previously unknown role in learning and memory formation.

23 Apr 2014

Study outlines how regulations on alcohol, tobacco may provide guidance to consequences of legalizing marijuana

As U.S. policymakers consider ways to ease prohibitions on marijuana, the public health approaches used to regulate alcohol and tobacco over the past century may provide valuable lessons, according to new RAND Corporation research.

22 Apr 2014

First Edition: April 16, 2014

Today's headlines include a report detailing how changes in the Census Bureau's annual survey could mask the health law's impact.

16 Apr 2014

ABAM Foundation accredits four new addiction medicine fellowship programs

The American Board of Addiction Medicine Foundation today announced the accreditation of four new addiction medicine fellowship programs, bringing the total number of accredited programs to 23.

11 Apr 2014

Researchers show development of new cell models that track, report clock gene function

The consequences of modern life -- shift work, cell phone addiction, and travel across time zones -- all disturb internal clocks. These are found in the brain where they regulate sleep and throughout the body where they regulate physiology and metabolism.

11 Apr 2014

Special Hazelden Betty Ford Foundation conference to focus on issues surrounding addiction

The Hazelden Betty Ford Foundation's Professionals in Residence program in collaboration with the University of Minnesota Department of Family Medicine and Community Health and the Scaife Family Foundation will host a special conference June 20-21 in Minnesota for primary health care providers to learn more about the issues surrounding addiction.

11 Apr 2014

Researcher develops novel IBT to help opioid-dependent Vermonters

Opioid dependence - addiction to heroin and prescription painkillers - has reached epidemic levels across the country, with treatment waitlists also at an all-time high.

11 Apr 2014

White House admits 'worrying about the wrong thing'

Top officials say they focused too much on whether enough insurance companies would participate and not enough on the smooth rollout of the exchange website, The New York Times reports.

11 Apr 2014

Studies shed light on propensity for habit formation in obsessive-compulsive disorder

Two new studies published this week in Biological Psychiatry shed light on the propensity for habit formation in obsessive-compulsive disorder (OCD). These studies suggest that a tendency to develop habits, i.e., the compulsive component of the disorder, may be a core feature of the disorder rather than a consequence of irrational beliefs.

11 Apr 2014

First Edition: April 10, 2014

Today's headlines include a range of stories taking additional looks at the Medicare physician payment data released yesterday by the Centers for Medicare & Medicaid Services.

10 Apr 2014

TSRI scientists to study effects of pain medication on prenatal brain development

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded a $472,500 Cutting Edge Basic Research Award (CEBRA) by the National Institute on Drug Abuse (NIDA) of the National Institutes of Health to study models of the brain development of newborns who have been exposed-and become addicted-to prescription pain medication while still in the womb.

10 Apr 2014

Small financial incentives can improve people’s completion of HBV vaccination, study finds

Small financial incentives, totalling as little as £30, can dramatically increase the likelihood of people who inject drugs completing a course of hepatitis B virus (HBV) vaccination, according to new research published in The Lancet.

10 Apr 2014

2014 PAINWeekEnd Regional Conference to highlight health crises of inadequate pain management

There are 116 million people in pain. There are 4,000 pain specialists. That's 29,000 patients per pain specialist. There are simply not enough pain specialists to go around.

9 Apr 2014

Alkermes announces results from phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia

Alkermes plc today announced positive topline results from a randomized, double-blind, placebo-controlled phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia. Patients treated once monthly with either 441 mg or 882 mg of aripiprazole lauroxil demonstrated statistically significant reductions from baseline in Positive and Negative Syndrome Scale (PANSS) total scores at week 12, compared to placebo (p<0.001 aripiprazole lauroxil 441 mg, p<0.001 aripiprazole lauroxil 882 mg), which was the prespecified primary endpoint in the study. Based on the positive results from this phase 3 study, Alkermes plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the third quarter of 2014.

8 Apr 2014

SLU researcher receives NIH grant to study on type of opioids that lead to depression

After finding a link between chronic use of prescription-based painkillers and increase in risk of depression, Saint Louis University researcher Jeffrey Scherrer, Ph.D., has received a $391,706 NIH grant to further investigate the pattern in a wider patient base, and study the type of opioids that lead to depression.

8 Apr 2014

Research roundup: Mental health parity; nurses' workload; can restaurants reduce portion size?

Historically, health insurance covered mental health care differently than other medical care. Recent laws have begun bringing them into balance. ... Congress passed the Mental Health Parity and Addiction Equity Act (MHPAEA) in 2008. ... the MHPAEA applied to large group health plans, both fully and self-insured, and included a cost exemption.

7 Apr 2014

BDSI enrolls first patient in Clonidine Topical Gel Phase 3 trial for treatment of painful diabetic neuropathy

BioDelivery Sciences International, Inc. announced today the enrollment of the first patient in the RHAPSODY Study, a Phase 3 clinical trial of Clonidine Topical Gel for the treatment of painful diabetic neuropathy.

3 Apr 2014

Addiction News and Research

UTMB awarded $6.6 million grant to establish Translational Addiction Sciences Center

Methadone safety: New clinical practice guideline from American Pain Society

UB research finds novel compound for treating cocaine addiction

TSRI scientists identify protein complex that plays critical role in learning and memory formation

Study outlines how regulations on alcohol, tobacco may provide guidance to consequences of legalizing marijuana

First Edition: April 16, 2014

ABAM Foundation accredits four new addiction medicine fellowship programs

Researchers show development of new cell models that track, report clock gene function

Special Hazelden Betty Ford Foundation conference to focus on issues surrounding addiction

Researcher develops novel IBT to help opioid-dependent Vermonters

White House admits 'worrying about the wrong thing'

Studies shed light on propensity for habit formation in obsessive-compulsive disorder

First Edition: April 10, 2014

TSRI scientists to study effects of pain medication on prenatal brain development

Small financial incentives can improve people’s completion of HBV vaccination, study finds

2014 PAINWeekEnd Regional Conference to highlight health crises of inadequate pain management

Alkermes announces results from phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia

SLU researcher receives NIH grant to study on type of opioids that lead to depression

Research roundup: Mental health parity; nurses' workload; can restaurants reduce portion size?

BDSI enrolls first patient in Clonidine Topical Gel Phase 3 trial for treatment of painful diabetic neuropathy

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News